2:20cv1402 • March 12, 2020
Class Period Start
February 13, 2020
Class Period End
November 6, 2020
PSLRA Deadline
May 12, 2020
Case Allegations
10b5
Statutes of Repose
Feb 13, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 19, 2022
Settlement Fund
$30,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) from February 14, 2020 through August 10, 2020, inclusive.
Claim Administrator
Gilardi & Co. LLC
Inovio Securities Litigation
Claims Administrator
c/o Gilardi & Co. LLC
P.O. Box 6162
Novato, CA 94948-6162
+1 866-809-3338
[email protected]
Settlement Website
www.InovioSecuritiesLitigation.comHearing Date
December 15, 2022
Opt-out Deadline
November 23, 2022
Settlement Note
Download hereProof Of Claim
Download here
Feb 1, 2023
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Aug 31, 2022
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Aug 31, 2022
The court has denied the request to proceed as a class action. This means the case cannot move forward on behalf of the proposed group of investors unless that decision changes or the court later approves a revised request.
Aug 31, 2022
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Aug 22, 2022
May 3, 2022
Mar 21, 2022
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Feb 24, 2022
Feb 17, 2022
A new complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Jan 24, 2022
Nov 5, 2021
Jul 29, 2021
Motion for Class Certification
The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.
Mar 25, 2021
Mar 12, 2021
Mar 3, 2021
Feb 16, 2021
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Nov 5, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Sep 21, 2020
A new complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Sep 21, 2020
Sep 18, 2020
Sep 17, 2020
Aug 3, 2020
A new complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Jul 1, 2020
Jun 18, 2020
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jun 8, 2020
Apr 27, 2020
Mar 12, 2020
A securities fraud class action complaint has been filed on behalf of certain investors in INOVIO PHARMACEUTICALS, INC..
TOP
